Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose oral minoxidil can cause serious side effects like heart issues, so use the lowest effective dose.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Mild changes in bone markers relate to TCM syndromes in CKD-MBD patients.

Rituximab may cause skin issues, but baricitinib can help improve them.

Antiandrogenic treatments can effectively manage certain skin conditions by using female hormones.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Doctors should use a detailed patient history and physical exam to diagnose joint pain, and consult a rheumatologist early for suspected autoimmune diseases.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Low-dose oral minoxidil effectively treats alopecia but can cause side effects like excess hair growth and fluid retention.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Skin issues from chronic graft-versus-host disease greatly affect daily life, needing teamwork between blood and skin doctors.

Mesenchymal stem cells improve skin appearance and structure in dermatology and aesthetic medicine.

Dystonia may be part of PAS-4 and linked to immune issues.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Mycophenolate mofetil may safely help restore skin color in depigmentation conditions.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Oral tacrolimus may be a potential treatment for hair loss that doesn't respond to corticosteroids.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

Enteral nutrition's role in maintaining Crohn's disease remission is unclear and needs more research.

Intralesional methotrexate and triamcinolone acetonide are more effective than Vitamin D3 for treating alopecia areata.